|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months显示文摘 | Meyrat P Safroneeva E Schoepfer AM | 2012 | Aliment Pharmacol Ther2012，36，1112： | 1 |
| 2 | Accuracy of four fecal assays in the diagnosis of colitis显示文摘 | Schoepfer AM Trummler M Seeholzer P | | 0，，10： | 1 |
| 3 | Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI显示文摘 | Schoepfer AM Beglinger C Straumann A | 2010 | Am J Gastroenterol2010，105，1： | 1 |
| 4 | Management of blunt injuries to the spleen 显示文摘 | Renzulli P Gross T Schoepfer AM | 2010 | Br J Surg2010，97，16： | 1 |
| 5 | Discriminating IBD from IBS : comparison of the test performance of fecal mark- ers, blood leukocytes, CRP and IBD antibodies 显示文摘 | Schoepfer AM Trummler M Seeholzer P | 2008 | Inflamm Bowel Dis2008，14，1： | 1 |
| 6 | Fecal cal- protectin correlates more closely with the Simple Endo- scopic Score for Crohnrs disease (SES-CD) than CRP, blood leukocytes,and the CDAI显示文摘 | Schoepfer AM Beglinger C Straumann A | 2010 | Am J Gastroenterol2010，105，1： | 1 |
| 7 | Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers显示文摘 | SCHOEPFER AM VAVRICKA S ZAHND-STRAUMANN N | 2012 | J Crohns Colitis2012，6，4： | 1 |
| 8 | Antibodies to flagellin indicate reactivity to bacterial antigens in IBS pa- tients显示文摘 | Schoepfer AM Schaffer T Seibold-Schmid B | 2008 | NeurogastroenterolMotil2008，20，10： | 1 |
| 9 | Phenotypic associa- tions of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss co- hort显示文摘 | Schoepfer AM Sehaffer T Mueller S | 2009 | Inflamm Bowel Dis2009，15，9： | 1 |
| 10 | Low Mannan-binding lecfin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA)显示文摘 | SCHOEPFER AM FLOGERZI B SEIBOLD-SCHMID B | 2009 | Am J Gas- troenterol2009，104，10： | 1 |
| 11 | Mood and nonmood components of perceived stress and exacerbation of Crohn's dis- ease显示文摘 | Cdmara RJ Schoepfer AM Pittet V | 2011 | Inflamm Bowel Dis2011，17，11： | 1 |
| 12 | Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI显示文摘 | Schoepfer AM Beglinger C Straumann A | 2010 | Am J Gastroenterol2010，105，1： | 1 |
| 13 | Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner显示文摘 | Schoepfer AM Safroneeva E Bussmann C | 2014 | Eur JGastroen Hepat2014，26，2： | 1 |
| 14 | Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population:results of the FACTS survey显示文摘 | Schoepfer AM Vavricka SR Binek J | | 0，，： | 1 |
| 15 | Systematic review of atraumatic splenic rupture 显示文摘 | Renzulli P Hostettler A Schoepfer AM | 2009 | Br J Surg2009，96，10： | 1 |
| 16 | Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes 显示文摘 | Schoepfer AM Beglinger C Straumann A | 2013 | Inflamm Bowel Dis2013，19，2： | 1 |
| 17 | Accuracy of four fecal assays in the diagnosis of colitis显示文摘 | Schoepfer AM Trummler M Seeholzer P | 2007 | Dis Colon Rectum2007，50，10： | 1 |
| 18 | Efficacy and safety of certolizumab pegol in an unselected crohn's disease population:26-week data of the FACTS II survey显示文摘 | Vavricka SR Schoepfer AM Bansky G | | 0，，： | 1 |
| 19 | How d9 gastroen- terologists assess overall activity of eosinophilic esophagtis in a- dult patients? 显示文摘 | Schoepfer AM Panczak R Zwahlen M | 2015 | Am J Gastroenterol2015，110，3： | 1 |
| 20 | Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients显示文摘 | Schoepfer AM Schaffer T Seibold-Schmid B | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员